The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Kratom has been used for hundreds of years in Southeast Asia for issues like fatigue. But it's banned in at least 6 states.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.